Skip to search.
 FTSE 100 Up 0.71%

Abbott Laboratories (ABT)

-NYSE
47.49 Down 0.83(1.72%) 27 Apr 21:00
|After Hours: : 47.60 Up 0.11 (0.23%) 22:54
Add to Portfolio
Prev Close:48.32
Open:48.28
Bid:47.11 x 100
Ask:47.86 x 300
1y Target Est:50.09
Beta:1.06
Earnings Date:14 Jul - 20 Jul (Est.)
Day's Range:47.38 - 48.40
52wk Range:38.25 - 48.62
Volume:5,254,539
Avg Vol (3m):5,458,580
Market Cap:71.66b
P/E (ttm):17.18
EPS (ttm):2.76
Div & Yield:0.96 (2.10%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 1.72%71.66b
NSRGYUp 0.03%N/A
RHHBYDown 0.10%N/A
TEVADown 4.32%52.50b

Key Statistics

Forward P/E (1 yr):19.79
P/S (ttm):3.58
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Jun-15) :0.50
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback